ArticleCancer chemotherapy and pharmacology2025

Population pharmacokinetics and exposure-response analysis of durvalumab in combination with gemcitabine and cisplatin in patients with advanced biliary tract cancer.

Aburough Abegesah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.